No abstract available
MeSH terms
-
Administration, Inhalation
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Animals
-
Endothelial Cells / enzymology
-
Endothelial Cells / metabolism
-
Heart Failure / drug therapy*
-
Heart Failure / etiology*
-
Heart Failure / physiopathology
-
Humans
-
Isosorbide Dinitrate / therapeutic use
-
Myocytes, Cardiac / enzymology
-
Myocytes, Cardiac / metabolism
-
Nitric Oxide / administration & dosage
-
Nitric Oxide / biosynthesis
-
Nitric Oxide / physiology*
-
Nitric Oxide Donors / therapeutic use
-
Nitric Oxide Synthase / physiology
-
Nitric Oxide Synthase Type I
-
Nitric Oxide Synthase Type II
-
Nitric Oxide Synthase Type III
Substances
-
Angiotensin-Converting Enzyme Inhibitors
-
Nitric Oxide Donors
-
Nitric Oxide
-
NOS1 protein, human
-
NOS2 protein, human
-
NOS3 protein, human
-
Nitric Oxide Synthase
-
Nitric Oxide Synthase Type I
-
Nitric Oxide Synthase Type II
-
Nitric Oxide Synthase Type III
-
Isosorbide Dinitrate